Literature DB >> 26310690

Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.

Ling Feng1, Jugao Fang2, Luo Zhang1, Huabin Li3, Bing Zhou1, Xiaohong Chen1, Yunchuan Li1, Demin Han1.   

Abstract

OBJECTIVE: Esthesioneuroblastoma (ENB) is an uncommon malignant tumor. During the past decade, endoscopic approaches have been gradually applied in treating skull base tumors. However, the experience in using this approach to treat ENB is still limited. Kadish staging and Dulguerov staging are common methods used for ENB staging, but it remains unclear as to which method is better. In this study, we reviewed our experiences with endoscopic surgeries for ENB and analyzed the prognostic roles of the two staging methods.
METHODS: A total of 24 patients with ENB treated with only endoscopic endonasal surgery between January 2001 and March 2012 were included. Overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan-Meier method and early and advanced stages were compared using the log-rank test. The prognostic roles of the two staging methods were also analyzed.
RESULTS: Amongst the 24 patients, 19 patients presented with newly diagnosed ENB, and 5 patients presented with recurrent disease. The three-year OS and DFS rates were 82% and 70.8%, respectively. Four patients (16.6%) died from recurrence of the tumor. Dulguerov staging predicted OS with significant differences (P=0.042), whereas Kadish staging predicted DFS with significant differences (P=0.020) between the early and advanced stages.
CONCLUSIONS: The present study showed experiences that purely endoscopic endonasal surgery for ENB showed successful survival results with remarkably decreased complications. Dulguerov staging and Kadish staging play different prognostic roles in patients treated with purely endoscopic endonasal resection based on various end points.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endoscopic endonasal resection; Esthesioneuroblastoma; Prognostic

Mesh:

Year:  2015        PMID: 26310690     DOI: 10.1016/j.clineuro.2015.08.006

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Olfactory neuroblastoma: a single-center experience.

Authors:  Marton König; Terje Osnes; Peter Jebsen; Jan Folkvard Evensen; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2017-05-25       Impact factor: 3.042

Review 2.  Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.

Authors:  Daniel B Spielman; Andi Liebowitz; Maeher Grewal; Chetan Safi; Jonathan B Overdevest; Alfred M Iloreta; Brett E Youngerman; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22

3.  Surgical Treatment of Olfactory Neuroblastoma: Major Complication Rates, Progression Free and Overall Survival.

Authors:  Aileen Wertz; Todd Hollon; Lawrence J Marentette; Stephen E Sullivan; Jonathan B McHugh; Erin L McKean
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-17

4.  Olfactory neuroblastoma treated with minimally invasive surgery and adjuvant radiotherapy: a case report and review of the literature.

Authors:  Domenico Cante; Cristina Piva; Piera Sciacero; Pierfrancesco Franco; Edoardo Petrucci; Valeria Casanova Borca; Fabrizio Marola; Libero Tubino; Giorgio Vellani; Maria Rosa La Porta
Journal:  BJR Case Rep       Date:  2018-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.